Quantitative changes in the level of assessed GAGs in plasma, which were observed in children with JIA during a biological therapy, seem to result from the effective inhibition of the key proinflammatory cytokine, i.e., TNF-α, which initiates the degradation of cartilage in patients [22]. This evidence concerns the gene TNF and juvenile idiopathic arthritis.